Income Taxes (Tables)

12 Months Ended

Dec. 31, 2012

Income Taxes [Abstract]

Summary of deferred tax assets

	2012			2011
Net operating loss carry forwards	$	27,872,000		$	26,001,000
Orphan drug and research and development credit carry forwards		3,068,000			2,818,000
Other		1,443,000			1,615,000
Total		32,383,000			30,434,000
Valuation allowance		(32,383,000	)		(30,434,000	)
Net deferred tax assets	$	-		$	-

Reconciliations of dfference between income tax benefit computed at federal and state statutory tax rates and provision for income tax benefit

	2012			2011
Income tax loss at federal statutory rate		(34.00	) %		(34.00	) %
State tax benefits, plus sale of NJ NOLs, net of federal benefit		(6.00	)		(6.00	)
Subtotal		(40.00	)		(40.00	)
Valuation allowance		28.87			20.56
Income tax benefit		(11.13	) %		(19.44	) %